ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly asset impairment, restructuring and other special charges ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Operations
Latest, FY2025
484
Period ended Dec 31, 2025
Change on a year earlier
-43.8%
861 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Asset impairment, restructuring and other special charges ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 484 | -43.8% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 861 | +1,166.2% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 68 | -72.2% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 245 | -22.6% | Form 10-K (filed 2025-02-19) ↗ |
| FY2021 | Dec 31, 2021 | 316 | +140.9% | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 131 | -77.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 576 | +115.7% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 267 | -80.0% | Form 10-K (filed 2021-02-17) ↗ |
| FY2017 | Dec 31, 2017 | 1,332 | +248.1% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 383 | +4.0% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 368 | -21.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 469 | +288.6% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 121 | -57.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 281 | -30.0% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 401 | +109.1% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 192 | -72.3% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 693 | -64.9% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 1,974 | +552.6% | Form 10-K (filed 2010-02-22) ↗ |
| FY2007 | Dec 31, 2007 | 303 | – | Form 10-K (filed 2010-02-22) ↗ |
Breakdown
What makes up asset impairment, restructuring and other special charges ($m)
Cite this data
StockData. (2026). Eli Lilly Asset impairment, restructuring and other special charges ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/restructuring_impairment
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.